SNGX Stock Posts

SNGX Soligenix1.62-0.21-11.5%

Premarket:1.12-0.50 (-30.9%)

Soligenix Announces Pricing of $7.5 Million Public Offering

PRNewswireFri, 26-Sep 6:33 AM

SNGX Soligenix1.61-0.03-1.8%

Premarket:2.17+0.56 (+34.8%)

Soligenix Announces Positive Progress in the Pre-clinical Development of its COVID-19 Vaccine

PRNewswireThu, 4-Mar 7:00 AM

SNGX Soligenix2.74+0.06+2.2%

Premarket:1.32-1.42 (-51.8%)

Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients

PRNewswireTue, 22-Dec 6:30 AM

SNGX Soligenix Inc.2.13-0.07-3.2%

Premarket:3.37+1.24 (+58.2%)

Soligenix Announces Publication of Positive Pre-clinical Results for a Novel COVID-19 Vaccine

PRNewswireTue, 28-Jul 7:00 AM

SNGX Soligenix Inc.1.40-0.12-7.9%

Premarket:2.55+1.15 (+82.1%)

Soligenix Announces Exclusive Licensing Agreement for Novel Vaccine Adjuvant from BTG Specialty Pharmaceuticals

PRNewswireThu, 16-Apr 7:00 AM